1-3 of 3
Aspasia Koudouna, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Soluble Syndecan-1 (ssCD138) Can Contribute to the Discrimination of Lenalidomide Resistant Multiple Myeloma (MM) Patients

Annita Ioanna Gkioka, MD, Aspasia Koudouna, MD, Vasiliki Bartzi, MD, Maria Dimou, MD PhD, Theodoros Iliakis, MD, Aikaterini Bitsani, MD, Vasileios Pardalis, MD, Panayiotis Panayiotidis, MD, Marie-Christine Kyrtsonis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-142006
Published: 2020
Journal Articles

Uninvolved Immunoglobulin Suppression Determined By "Hevylite" ASSAY. Strongly Predicts Evolution of Smoldering Myeloma (SMM) to Symptomatic Multiple Myeloma (MM)

Paraskevi Papaioannou, MD, Annita Ioanna Gkioka, MD, Kallirroi Tsalimalma, MD, Aspasia Koudouna, MD, Anastasia Kopsaftopoulou, MD, Konstantina Chamoulkou, MD, Ioannis Grafakos, MD, Aikaterini Bitsani, MD, Theodoros Iliakis, MD, Maria Dimou, MD PhD, Nikolitsa Kafassi, MD, Petros Sfikakis, MD PhD, Panayiotis Panayiotidis, MD PhD, Marie-Christine Kyrtsonis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5584.
https://doi.org/10.1182/blood-2018-99-118631
Published: 2018
Journal Articles

Increased SERUM VON Willebrand Levels in Chronic Lymphocytic Leukemia (CLL) Patients Are Related to a Shorter Time to Treatment

Thommais Tryfou, MLS, Paraskevi Papaioannou, MD, Panagiotis Repousis, MD, Annita Ioanna Gkioka, MD, Sotirios Sachanas, Aikaterini Bitsani, MD, Maria Dimou, MD PhD, Dimitrios Maltezas, Aspasia Koudouna, MD, Anastasia Kopsaftopoulou, MD, Konstantina Chamoulkou, MD, Ioannis Grafakos, MD, Styliani Kokori, MD, Argyrios Tsantes, MD, Gerasimos Pangalis, MD, Panayiotis Panayiotidis, MD PhD, Marie-Christine Kyrtsonis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5547.
https://doi.org/10.1182/blood-2018-99-119520
Published: 2018